157 related articles for article (PubMed ID: 20584535)
1. Thoracic metastasectomy for adoptive immunotherapy of melanoma: a single-institution experience.
Klapper JA; Davis JL; Ripley RT; Smith FO; Nguyen DM; Kwong KF; Mercedes L; Kemp CD; Mathur A; White DE; Dudley ME; Wunderlich JR; Rosenberg SA; Schrump DS
J Thorac Cardiovasc Surg; 2010 Dec; 140(6):1276-82. PubMed ID: 20584535
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.
Chandran SS; Somerville RPT; Yang JC; Sherry RM; Klebanoff CA; Goff SL; Wunderlich JR; Danforth DN; Zlott D; Paria BC; Sabesan AC; Srivastava AK; Xi L; Pham TH; Raffeld M; White DE; Toomey MA; Rosenberg SA; Kammula US
Lancet Oncol; 2017 Jun; 18(6):792-802. PubMed ID: 28395880
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients.
Ridolfi R; Flamini E; Riccobon A; De Paola F; Maltoni R; Gardini A; Ridolfi L; Medri L; Poletti G; Amadori D
Cancer Immunol Immunother; 1998 Jun; 46(4):185-93. PubMed ID: 9671141
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma.
Alvarez-Downing MM; Inchauste SM; Dudley ME; White DE; Wunderlich JR; Rosenberg SA; Kammula US
World J Surg Oncol; 2012 Jun; 10():113. PubMed ID: 22726267
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma.
Ridolfi L; Ridolfi R; Riccobon A; De Paola F; Petrini M; Stefanelli M; Flamini E; Ravaioli A; Verdecchia GM; Trevisan G; Amadori D
J Immunother; 2003; 26(2):156-62. PubMed ID: 12616107
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.
Corsini EM; Mitchell KG; Zhou N; Bernatchez C; Forget MA; Haymaker CL; Hofstetter WL; Mehran RJ; Rajaram R; Rice DC; Roth JA; Sepesi B; Swisher SG; Vaporciyan AA; Walsh GL; Amaria RN; Jazaeri AA; Antonoff MB
J Surg Oncol; 2021 Sep; 124(4):699-703. PubMed ID: 34057733
[TBL] [Abstract][Full Text] [Related]
7. Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.
Besser MJ; Shapira-Frommer R; Treves AJ; Zippel D; Itzhaki O; Hershkovitz L; Levy D; Kubi A; Hovav E; Chermoshniuk N; Shalmon B; Hardan I; Catane R; Markel G; Apter S; Ben-Nun A; Kuchuk I; Shimoni A; Nagler A; Schachter J
Clin Cancer Res; 2010 May; 16(9):2646-55. PubMed ID: 20406835
[TBL] [Abstract][Full Text] [Related]
8. Survival and Local Recurrence After Video-Assisted Thoracoscopic Lung Metastasectomy.
Abdelnour-Berchtold E; Perentes JY; Ris HB; Beigelman C; Lovis A; Peters S; Krueger T; Gonzalez M
World J Surg; 2016 Feb; 40(2):373-9. PubMed ID: 26464153
[TBL] [Abstract][Full Text] [Related]
9. Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.
Klemen ND; Feingold PL; Goff SL; Hughes MS; Kammula US; Yang JC; Schrump DS; Rosenberg SA; Sherry RM
Ann Surg Oncol; 2017 Jan; 24(1):135-141. PubMed ID: 27638681
[TBL] [Abstract][Full Text] [Related]
10. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study].
Verdecchia GM; Ridolfi L; Ridolfi R; Riccobon A; Bertagni A; Vagliasindi A; Petrini M; Stefanelli M; Milandri C; Amadori D
Tumori; 2003; 89(4 Suppl):298-300. PubMed ID: 12903626
[TBL] [Abstract][Full Text] [Related]
12. Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating Lymphocytes.
Ben-Avi R; Itzhaki O; Simansky D; Zippel D; Markel G; Ben Nun A; Schachter J; Besser MJ
J Immunother; 2016 Jun; 39(5):218-22. PubMed ID: 27163742
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of adoptive cell transfer of tumor-infiltrating lymphocytes after lymphopenia induction for metastatic melanoma.
Pilon-Thomas S; Kuhn L; Ellwanger S; Janssen W; Royster E; Marzban S; Kudchadkar R; Zager J; Gibney G; Sondak VK; Weber J; Mulé JJ; Sarnaik AA
J Immunother; 2012 Oct; 35(8):615-20. PubMed ID: 22996367
[TBL] [Abstract][Full Text] [Related]
14. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.
Rosenberg SA; Yang JC; Sherry RM; Kammula US; Hughes MS; Phan GQ; Citrin DE; Restifo NP; Robbins PF; Wunderlich JR; Morton KE; Laurencot CM; Steinberg SM; White DE; Dudley ME
Clin Cancer Res; 2011 Jul; 17(13):4550-7. PubMed ID: 21498393
[TBL] [Abstract][Full Text] [Related]
15. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax.
Tafra L; Dale PS; Wanek LA; Ramming KP; Morton DL
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):119-28; discussion 129. PubMed ID: 7609535
[TBL] [Abstract][Full Text] [Related]
16. Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.
Goff SL; Dudley ME; Citrin DE; Somerville RP; Wunderlich JR; Danforth DN; Zlott DA; Yang JC; Sherry RM; Kammula US; Klebanoff CA; Hughes MS; Restifo NP; Langhan MM; Shelton TE; Lu L; Kwong ML; Ilyas S; Klemen ND; Payabyab EC; Morton KE; Toomey MA; Steinberg SM; White DE; Rosenberg SA
J Clin Oncol; 2016 Jul; 34(20):2389-97. PubMed ID: 27217459
[TBL] [Abstract][Full Text] [Related]
17. Liver resection for metastatic melanoma with postoperative tumor-infiltrating lymphocyte therapy.
Ripley RT; Davis JL; Klapper JA; Mathur A; Kammula U; Royal RE; Yang JC; Sherry RM; Hughes MS; Libutti SK; White DE; Steinberg SM; Dudley ME; Rosenberg SA; Avital I
Ann Surg Oncol; 2010 Jan; 17(1):163-70. PubMed ID: 19777192
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases.
Mehta GU; Malekzadeh P; Shelton T; White DE; Butman JA; Yang JC; Kammula US; Goff SL; Rosenberg SA; Sherry RM
J Immunother; 2018 Jun; 41(5):241-247. PubMed ID: 29672342
[TBL] [Abstract][Full Text] [Related]
19. Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
Medina BD; Choi BH; Rodogiannis KG; Moran U; Shapiro RL; Pavlick A; Osman I; Berman RS; Lee AY
J Surg Oncol; 2020 Sep; 122(3):555-561. PubMed ID: 32441371
[TBL] [Abstract][Full Text] [Related]
20. Tissue Harvesting for Adoptive Tumor Infiltrating Lymphocyte Therapy in Metastatic Melanoma.
Zippel D; Friedman-Eldar O; Rayman S; Hazzan D; Nissan A; Schtrechman G; Markel G; Schachter J; Itzhaki O; Besser MJ
Anticancer Res; 2019 Sep; 39(9):4995-5001. PubMed ID: 31519606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]